These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 8752176

  • 1. An experimental model of bone metastasis by human lung cancer cells: the role of parathyroid hormone-related protein in bone metastasis.
    Iguchi H, Tanaka S, Ozawa Y, Kashiwakuma T, Kimura T, Hiraga T, Ozawa H, Kono A.
    Cancer Res; 1996 Sep 01; 56(17):4040-3. PubMed ID: 8752176
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Characterization of a renal cell carcinoma cell line derived from a human bone metastasis and establishment of an experimental nude mouse model.
    Weber KL, Pathak S, Multani AS, Price JE.
    J Urol; 2002 Aug 01; 168(2):774-9. PubMed ID: 12131367
    [Abstract] [Full Text] [Related]

  • 4. Humanized monoclonal antibody against parathyroid hormone-related protein suppresses osteolytic bone metastasis of human breast cancer cells derived from MDA-MB-231.
    Saito H, Tsunenari T, Onuma E, Sato K, Ogata E, Yamada-Okabe H.
    Anticancer Res; 2005 Aug 01; 25(6B):3817-23. PubMed ID: 16309168
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E, Azuma Y, Saito H, Tsunenari T, Watanabe T, Hirabayashi M, Sato K, Yamada-Okabe H, Ogata E.
    Clin Cancer Res; 2005 Jun 01; 11(11):4198-203. PubMed ID: 15930357
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Interleukin-4 inhibits spontaneous and parathyroid hormone-related protein-stimulated osteoclast formation in mice.
    Nakano Y, Watanabe K, Morimoto I, Okada Y, Ura K, Sato K, Kasono K, Nakamura T, Eto S.
    J Bone Miner Res; 1994 Oct 01; 9(10):1533-9. PubMed ID: 7817798
    [Abstract] [Full Text] [Related]

  • 11. Parathyroid hormone-related protein varies with sex and androgen status in nonsmall cell lung cancer.
    Montgrain PR, Quintana R, Rascon Y, Burton DW, Deftos LJ, Casillas A, Hastings RH.
    Cancer; 2007 Sep 15; 110(6):1313-20. PubMed ID: 17676588
    [Abstract] [Full Text] [Related]

  • 12. Direct evidence that PTHrP expression promotes prostate cancer progression in bone.
    Deftos LJ, Barken I, Burton DW, Hoffman RM, Geller J.
    Biochem Biophys Res Commun; 2005 Feb 11; 327(2):468-72. PubMed ID: 15629138
    [Abstract] [Full Text] [Related]

  • 13. Parathyroid hormone-related protein as a growth regulator of prostate carcinoma.
    Dougherty KM, Blomme EA, Koh AJ, Henderson JE, Pienta KJ, Rosol TJ, McCauley LK.
    Cancer Res; 1999 Dec 01; 59(23):6015-22. PubMed ID: 10606251
    [Abstract] [Full Text] [Related]

  • 14. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
    Nemeth JA, Harb JF, Barroso U, He Z, Grignon DJ, Cher ML.
    Cancer Res; 1999 Apr 15; 59(8):1987-93. PubMed ID: 10213511
    [Abstract] [Full Text] [Related]

  • 15. A murine model of experimental metastasis to bone and bone marrow.
    Arguello F, Baggs RB, Frantz CN.
    Cancer Res; 1988 Dec 01; 48(23):6876-81. PubMed ID: 3180096
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line.
    Price JT, Quinn JM, Sims NA, Vieusseux J, Waldeck K, Docherty SE, Myers D, Nakamura A, Waltham MC, Gillespie MT, Thompson EW.
    Cancer Res; 2005 Jun 01; 65(11):4929-38. PubMed ID: 15930315
    [Abstract] [Full Text] [Related]

  • 18. Reveromycin A inhibits osteolytic bone metastasis of small-cell lung cancer cells, SBC-5, through an antiosteoclastic activity.
    Muguruma H, Yano S, Kakiuchi S, Uehara H, Kawatani M, Osada H, Sone S.
    Clin Cancer Res; 2005 Dec 15; 11(24 Pt 1):8822-8. PubMed ID: 16361571
    [Abstract] [Full Text] [Related]

  • 19. Involvement of parathyroid hormone-related protein in experimental cachexia induced by a human lung cancer-derived cell line established from a bone metastasis specimen.
    Iguchi H, Onuma E, Sato K, Sato K, Ogata E.
    Int J Cancer; 2001 Oct 01; 94(1):24-7. PubMed ID: 11668474
    [Abstract] [Full Text] [Related]

  • 20. Synergistic inhibitory activity of zoledronate and paclitaxel on bone metastasis in nude mice.
    Lu S, Zhang J, Zhou Z, Liao ML, He WZ, Zhou XY, Li ZM, Xiang JQ, Wang JJ, Chen HQ.
    Oncol Rep; 2008 Sep 01; 20(3):581-7. PubMed ID: 18695909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.